Tuesday, November 19, 2024
- 11:00AM-12:30PM
-
Abstract Number: 2659
A Comprehensive Approach Utilizing a Combination of Genetics, Cytological Analysis, and Imaging Techniques to Speed up the Diagnostic Process in VEXAS Patients
Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II- 11:00AM-12:30PM
-
Abstract Number: 2663
ADI-001: An Allogeneic CD20-targeted γδ CAR T Cell Therapy with Potential for Improved Tissue Homing in Autoimmune Indications
Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II- 11:00AM-12:30PM
-
Abstract Number: 2690
ANCA IgG Promotion of Neutrophil Recruitment, Migration and Vascular Damage in ANCA Associated Vasculitis May Be Enhanced by Hypoxia
Abstracts: Vasculitis – ANCA-Associated II- 11:00AM-12:30PM
-
Abstract Number: 2667
Anti-Mi2 Autoantibodies in Dermatomyositis Patients Also Recognize Autoimmune Regulator (AIRE) Protein
Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II- 11:00AM-12:30PM
-
Abstract Number: 2684
Assessment of Skin in Patients with Systemic Sclerosis Using High Frequency Ultrasound : A Comparative Study with Histology and Clinical Parameters of Skin Disease
Abstracts: Systemic Sclerosis & Related Disorders – Clinical III- 11:00AM-12:30PM
-
Abstract Number: 2685
Association Between Gastrointestinal Bacterial Species and Radiological Features of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): A Multicenter Study from the SSc Microbiome Consortium Project
Abstracts: Systemic Sclerosis & Related Disorders – Clinical III- 11:00AM-12:30PM
-
Abstract Number: 2681
Association of Social Determinants of Health with Systemic Lupus Erythematosus in the United States: Nationally Representative Estimates for 2017-2021
Abstracts: SLE – Diagnosis, Manifestations, & Outcomes III: Targets, Outcomes & Comorbidity- 11:00AM-12:30PM
-
Abstract Number: 2694
Associations Between Immune Checkpoint Molecules and Nasal Microbiome in ANCA-associated Vasculitis
Abstracts: Vasculitis – ANCA-Associated II- 11:00AM-12:30PM
-
Abstract Number: 2665
Autoantibody Titers Against Specific Epitope Peptides Predict Treatment Resistance in Interstitial Lung Disease Associated with Anti-MDA5 Dermatomyositis
Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II- 11:00AM-12:30PM
-
Abstract Number: 2664
BCMA-targeted Bispecific T Cell-engager Therapy of Autoimmune Disease
Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II- 11:00AM-12:30PM
-
Abstract Number: 2661
Changes in Krebs Von Den Lungen 6 Levels (∆KL6) Predict Fibrosing Progression of Interstitial Lung Disease in Patients with an Underlying Connective Tissue Disease (CTD-ILD)
Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II- 11:00AM-12:30PM
-
Abstract Number: 2673
Changes in Mortality Risk After Stopping Glucocorticosteroids – a Population-based Study in Rheumatoid Arthritis
Abstracts: RA – Treatment II: Refining Use of Established Therapies- 11:00AM-12:30PM
-
Abstract Number: 2689
Characterization of Alpha-1 Antitrypsin Function in ANCA-Associated Vasculitis